Clinical Trial Update: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ONO-2020 in adults with mild to moderate Alzheimer's disease, noting the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ONO-2020

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Alzheimer Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING